Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
17.19
Dollar change
+0.08
Percentage change
0.47
%
IndexRUT P/E7.72 EPS (ttm)2.23 Insider Own1.15% Shs Outstand63.31M Perf Week2.75%
Market Cap1.07B Forward P/E17.02 EPS next Y1.01 Insider Trans0.00% Shs Float61.73M Perf Month5.98%
Income181.39M PEG0.40 EPS next Q0.23 Inst Own118.81% Short Float18.26% Perf Quarter17.02%
Sales325.39M P/S3.30 EPS this Y-49.55% Inst Trans-2.47% Short Ratio20.38 Perf Half Y7.10%
Book/sh11.21 P/B1.53 EPS next Y-9.01% ROA15.13% Short Interest11.27M Perf Year34.61%
Cash/sh2.86 P/C6.02 EPS next 5Y19.34% ROE28.67% 52W Range12.22 - 17.53 Perf YTD7.17%
Dividend Est.- P/FCF7.06 EPS past 5Y-9.02% ROI15.75% 52W High-1.97% Beta0.58
Dividend TTM- Quick Ratio9.17 Sales past 5Y1146.35% Gross Margin74.91% 52W Low40.67% ATR (14)0.36
Dividend Ex-DateSep 08, 2015 Current Ratio10.42 EPS Y/Y TTM-15.74% Oper. Margin33.74% RSI (14)66.43 Volatility2.16% 1.99%
Employees112 Debt/Eq0.64 Sales Y/Y TTM-1.84% Profit Margin55.75% Recom2.00 Target Price16.00
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q10.39% Payout0.00% Rel Volume0.69 Prev Close17.11
Sales Surprise13.96% EPS Surprise170.59% Sales Q/Q1.41% EarningsMay 08 AMC Avg Volume553.14K Price17.19
SMA204.01% SMA506.51% SMA20013.32% Trades Volume383,307 Change0.47%
Date Action Analyst Rating Change Price Target Change
Jun-18-24Initiated Cantor Fitzgerald Overweight
Jul-20-22Initiated Goldman Neutral $16
Nov-20-17Initiated Deutsche Bank Hold $13
Jul-09-24 01:30PM
Jun-27-24 08:00AM
Jun-18-24 09:51AM
Jun-03-24 07:00AM
May-31-24 07:30AM
04:06AM Loading…
May-20-24 04:06AM
May-10-24 02:04PM
May-08-24 10:57PM
05:09PM
04:05PM
07:00AM
Apr-24-24 07:00AM
Mar-04-24 04:01PM
Feb-29-24 04:56PM
04:37PM
04:05PM Loading…
04:05PM
Feb-14-24 02:44AM
Jan-10-24 06:16PM
Nov-18-23 07:03AM
Nov-03-23 06:00AM
Nov-01-23 05:32PM
04:15PM
04:05PM
Sep-19-23 08:30AM
Sep-18-23 08:00AM
Aug-25-23 04:52PM
Aug-02-23 05:18PM
04:05PM
Jul-23-23 09:22AM
Jul-11-23 08:53PM
08:00AM Loading…
08:00AM
Jul-06-23 11:33AM
Jun-26-23 01:27AM
Jun-21-23 08:00PM
Jun-07-23 08:30AM
Jun-06-23 04:05PM
May-24-23 01:49PM
May-23-23 06:42PM
May-11-23 06:45PM
07:42AM
May-09-23 07:45PM
04:32PM
Apr-28-23 05:30PM
Apr-26-23 08:00PM
Apr-18-23 11:22AM
Apr-17-23 04:31PM
09:40AM
09:00AM
Apr-10-23 08:38AM
Apr-05-23 10:05AM
09:53AM
Apr-03-23 12:09PM
Mar-13-23 06:24PM
Feb-28-23 04:10PM
Feb-14-23 04:33PM
Feb-13-23 05:09AM
Jan-23-23 11:07AM
Jan-10-23 04:05PM
Jan-03-23 06:15PM
Dec-28-22 06:15PM
11:07AM
Dec-22-22 06:00PM
Dec-16-22 06:00PM
Nov-30-22 04:30PM
Nov-28-22 09:40AM
Nov-18-22 08:48AM
Nov-17-22 07:11AM
Nov-11-22 09:40AM
05:29AM
Nov-09-22 06:35PM
04:05PM
Oct-31-22 09:40AM
Oct-20-22 10:02AM
Oct-19-22 10:01AM
08:00AM
Oct-14-22 12:20PM
Oct-12-22 08:30AM
Sep-19-22 02:28PM
Sep-08-22 07:00AM
Sep-05-22 11:43AM
Aug-22-22 08:55AM
Jul-27-22 05:55PM
04:05PM
Jul-21-22 11:08AM
Jul-20-22 10:01AM
Jul-14-22 06:04PM
Jul-13-22 05:29PM
04:32PM
04:25PM
Jul-12-22 01:35PM
Jul-11-22 05:07PM
09:17AM
08:14AM
07:32AM
Jul-08-22 08:35AM
May-24-22 03:03PM
02:06PM
May-23-22 10:04AM
08:30AM
Apr-27-22 06:45PM
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhen MarianneChief Accounting OfficerNov 15 '23Sale13.9910,994153,81040,158Nov 17 04:30 PM